Drug
Bubpivacaine
Bubpivacaine is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
33%
Ph not_applicable
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
Completed1
Enrolling by invitation1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (50.0%)
N/A1 (50.0%)
Trials by Status
completed133%
enrolling_by_invitation133%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
enrolling_by_invitationphase_1
Dexamethasone vs Dexmedetomidine in Sphenopalatine Ganglion Block for Rhinoplasty Pain
NCT07380139
completednot_applicable
Erector Spinae Plane Block as Analgesia in Patients for Colectomy
NCT06957574
unknown
U.S. Guided Erector Spinae Block for Postoperative Pain Management in Paraumbilical Hernia Repair Patients
NCT06120088
Clinical Trials (3)
Showing 3 of 3 trials
NCT07380139Phase 1
Dexamethasone vs Dexmedetomidine in Sphenopalatine Ganglion Block for Rhinoplasty Pain
NCT06957574Not Applicable
Erector Spinae Plane Block as Analgesia in Patients for Colectomy
NCT06120088
U.S. Guided Erector Spinae Block for Postoperative Pain Management in Paraumbilical Hernia Repair Patients
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3